Pfizer: Plans For Boosters Will Not Divert Supplies From Poorer Nations
Manufacturing Output Could End Vaccine Inequity In 2022
Pfizer and BioNTech expect to supply 3 billion doses of vaccine this year, with 41% going to lower and middle income countries. 
